News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,572 Results
Type
Article (3177)
Company Profile (11)
Press Release (33384)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (11983)
Career Advice (104)
Deals (1374)
Drug Delivery (5)
Drug Development (3539)
Employer Resources (4)
FDA (598)
Job Trends (784)
News (17494)
Policy (1250)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
Academia (423)
Academic (1)
Adcomms (1)
Allergies (3)
Alliances (4098)
ALS (2)
Alzheimer's disease (49)
Antibody-drug conjugate (ADC) (4)
Approvals (601)
Artificial intelligence (22)
Autoimmune disease (1)
Bankruptcy (17)
Best Places to Work (550)
BIOSECURE Act (2)
Biotechnology (8)
Bladder cancer (2)
Brain cancer (2)
Breast cancer (8)
Cancer (83)
Cardiovascular disease (4)
Career advice (91)
Career pathing (5)
CAR-T (10)
Cell therapy (32)
Clinical research (2652)
Collaboration (81)
Compensation (3)
Complete response letters (1)
COVID-19 (269)
CRISPR (7)
C-suite (17)
Cystic fibrosis (13)
Data (79)
Decentralized trials (1)
Denatured (3)
Depression (1)
Diabetes (8)
Diagnostics (504)
Diversity, equity & inclusion (1)
Drug discovery (16)
Drug pricing (3)
Earnings (2307)
Employer branding (1)
Employer resources (3)
Events (4067)
Executive appointments (55)
FDA (639)
Featured Employer (1)
Funding (63)
Gene editing (8)
Generative AI (3)
Gene therapy (15)
GLP-1 (23)
Government (330)
Guidances (1)
Healthcare (748)
Immunology and inflammation (7)
Indications (1)
Infectious disease (284)
Inflammatory bowel disease (5)
Influenza (7)
Intellectual property (7)
Interviews (13)
IPO (516)
IRA (1)
Job creations (249)
Job search strategy (85)
Labor market (2)
Layoffs (24)
Leadership (2)
Legal (172)
Liver cancer (4)
Lung cancer (9)
Lymphoma (10)
Machine learning (1)
Management (1)
Manufacturing (21)
MASH (2)
Medical device (660)
Medtech (661)
Mergers & acquisitions (870)
Metabolic disorders (19)
Multiple sclerosis (1)
Neurodegenerative disease (4)
Neuroscience (65)
NextGen: Class of 2025 (328)
Non-profit (368)
Northern California (83)
Now hiring (1)
Obesity (9)
Opinion (15)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (2)
Parkinson's disease (4)
Partnered (5)
Patents (11)
Patient recruitment (5)
Peanut (1)
People (4639)
Pharmaceutical (2)
Phase I (925)
Phase II (1234)
Phase III (823)
Pipeline (42)
Policy (13)
Postmarket research (60)
Preclinical (516)
Press Release (23)
Prostate cancer (2)
Radiopharmaceuticals (5)
Rare diseases (23)
Real estate (562)
Recruiting (2)
Regulatory (852)
Reports (4)
Research institute (440)
Resumes & cover letters (11)
RSV (1)
Series A (9)
Series B (6)
Service/supplier (1)
Sickle cell disease (1)
Southern California (65)
Spinal muscular atrophy (10)
Startups (374)
Supply chain (5)
Tariffs (3)
The Weekly (1)
United States (952)
Vaccines (48)
Venture capitalists (3)
Weight loss (2)
Women's health (5)
Date
Today (4)
Last 7 days (25)
Last 30 days (112)
Last 365 days (1489)
2025 (440)
2024 (1599)
2023 (2000)
2022 (2799)
2021 (2988)
2020 (3121)
2019 (2460)
2018 (1964)
2017 (2224)
2016 (2006)
2015 (2352)
2014 (1758)
2013 (1592)
2012 (1287)
2011 (1474)
2010 (1325)
Location
Africa (52)
Alabama (4)
Arizona (2)
Asia (2845)
Australia (601)
California (196)
Canada (86)
China (38)
Colorado (7)
Connecticut (8)
Delaware (3)
Europe (5132)
Florida (21)
Georgia (53)
Idaho (1)
Illinois (12)
India (1)
Indiana (5)
Iowa (2)
Japan (4)
Kansas (7)
Maine (1)
Maryland (42)
Massachusetts (182)
Michigan (6)
Minnesota (51)
Missouri (12)
Montana (1)
Nebraska (1)
New Hampshire (1)
New Jersey (82)
New Mexico (1)
New York (80)
North Carolina (26)
North Dakota (1)
Northern California (83)
Ohio (14)
Oregon (1)
Pennsylvania (63)
Rhode Island (7)
South America (64)
South Carolina (1)
Southern California (65)
Tennessee (5)
Texas (34)
Utah (1)
Virginia (13)
Washington D.C. (4)
Washington State (29)
West Virginia (1)
Wisconsin (2)
36,572 Results for "harbour biomed".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
April 9, 2025
·
3 min read
Press Releases
Harbour BioMed Reports Full Year 2024 Financial Results
April 1, 2025
·
14 min read
Press Releases
Harbour BioMed Announces Business Progress and Update
February 13, 2025
·
3 min read
Press Releases
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies
March 12, 2025
·
3 min read
Press Releases
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
March 24, 2025
·
3 min read
Press Releases
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development
February 20, 2025
·
5 min read
Press Releases
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
February 5, 2025
·
4 min read
Genetown
Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
Harbour BioMed (the “Company"; HKEX: 02142) announces that it has resubmitted the Biologics License Application (BLA) of batoclimab (HBM9161) to the National Medical Products Administration (NMPA) of China for the treatment of generalized myasthenia gravis (gMG).
June 26, 2024
·
4 min read
Press Releases
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
November 14, 2024
·
3 min read
Business
Harbour BioMed Announces Positive Profit Alert
Harbour BioMed announces a positive profit alert for the year ended December 31, 2023.
January 18, 2024
·
3 min read
1 of 3,658
Next
